{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:11:02Z","timestamp":1787227862334,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.02.081","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T16:52:09Z","timestamp":1174323129000},"page":"4273-4282","source":"Crossref","is-referenced-by-count":51,"title":["Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins"],"prefix":"10.1016","volume":"25","author":[{"given":"Robert P.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.02.081_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2007.02.081_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.vaccine.2007.02.081_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/bi0356698","article-title":"Uptake of botulinum neurotoxin into cultured neurons","volume":"43","author":"Keller","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2007.02.081_bib4","first-page":"53","article-title":"Phage-conversion of toxigenicity in Clostridium botulinum types C and D","volume":"24","author":"Inoue","year":"1971","journal-title":"Jpn J Microbiol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0022-3565(24)36519-X","article-title":"In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic, and molecular biologic approaches","volume":"280","author":"Coffield","year":"1997","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.vaccine.2007.02.081_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A","volume":"278","author":"Foran","year":"2003","journal-title":"J Biol Chem"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2007.02.081_bib7","first-page":"153","article-title":"Different types of botulinum toxin in humans","author":"Eleopra","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.vaccine.2007.02.081_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/0140-6736(90)93157-K","article-title":"Infant botulism due to Clostridium botulinum type C toxin","volume":"336","author":"Oguma","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.02.081_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/109.2.107","article-title":"Clostridium botulinum type F with recent observations on other types","volume":"109","author":"Dolman","year":"1961","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.02.081_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1637\/7347-022305R1.1","article-title":"Characterization of the neurotoxin produced by isolates associated with avian botulism","volume":"49","author":"Takeda","year":"2005","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2007.02.081_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1292\/jvms.68.325","article-title":"Protective effect of botulinum C\/D mosaic toxoid against avian botulism","volume":"68","author":"Takeda","year":"2006","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2007.02.081_bib12","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/JCM.42.10.4718-4725.2004","article-title":"Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland","volume":"42","author":"Lindstrom","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0006-291X(90)90828-B","article-title":"The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome","volume":"171","author":"Kimura","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib14","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1093\/nar\/18.16.4924","article-title":"Nucleotide sequence of Clostridium botulinum C1 neurotoxin","volume":"18","author":"Hauser","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2007.02.081_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1348-0421.1998.tb02330.x","article-title":"Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873","volume":"42","author":"Nakajima","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1292\/jvms.54.905","article-title":"The complete amino acid sequence of the Clostridium botulinum type D neurotoxin, deduced by nucleotide sequence analysis of the encoding phage d-16 phi genome","volume":"54","author":"Sunagawa","year":"1992","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2007.02.081_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/AEM.47.6.1319-1322.1984","article-title":"Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains","volume":"47","author":"Ochanda","year":"1984","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.43.2.584-588.1984","article-title":"Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies","volume":"43","author":"Oguma","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/IAI.48.2.312-317.1985","article-title":"Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813","volume":"48","author":"Terajima","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib20","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.57.9.2886-2891.1989","article-title":"Molecular diversity of neurotoxins from Clostridium botulinum type D strains","volume":"57","author":"Moriishi","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AEM.62.2.662-667.1996","article-title":"Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms","volume":"62","author":"Moriishi","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-4781(96)00006-1","article-title":"Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms","volume":"1307","author":"Moriishi","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2007.02.081_bib23","doi-asserted-by":"crossref","first-page":"12142","DOI":"10.1073\/pnas.93.22.12142","article-title":"The N-end rule: Function, mysteries, uses","volume":"93","author":"Varshavsky","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.081_bib24","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/bp025516w","article-title":"Design of methanol feed control in Pichia pastoris fermentations based upon a growth model","volume":"6","author":"Zhang","year":"2002","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2007.02.081_bib25","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/mds.20009","article-title":"Roads from vaccines to therapies","volume":"19","author":"Smith","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.vaccine.2007.02.081_bib26","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotropic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2007.02.081_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pep.2005.08.015","article-title":"Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris","volume":"45","author":"Dux","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2007.02.081_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin serotype F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2007.02.081_bib30","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","first-page":"427","article-title":"Vaccines for the prevention of botulism","author":"Smith","year":"2002"},{"key":"10.1016\/j.vaccine.2007.02.081_bib31","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"Smith","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains","volume":"189","author":"Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<569::AID-JNR9>3.0.CO;2-A","article-title":"Syntaxin and 25-kDa synapsomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival","volume":"52","author":"Williamson","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.vaccine.2007.02.081_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1388-2457(02)00103-7","article-title":"Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysical study by motor units counting","volume":"113","author":"Eleopra","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.vaccine.2007.02.081_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1016570810004","article-title":"Avian disease at the Salton Sea","volume":"473","author":"Friend","year":"2002","journal-title":"Hydrobiologia"},{"key":"10.1016\/j.vaccine.2007.02.081_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7589\/0090-3558-40.3.414","article-title":"Prevalence of neurotoxic Clostridium botulinum type C in the gastrointestinal tracts of tilapia (Oreochromis mossambicus) in the Salton Sea","volume":"40","author":"Nol","year":"2004","journal-title":"J Wild Dis"},{"key":"10.1016\/j.vaccine.2007.02.081_bib37","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.71.5.2941-2944.2003","article-title":"Expression of Hc subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice","volume":"71","author":"Woodward","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.081_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CDLI.11.3.496-502.2004","article-title":"Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum type C and D neurotoxins","volume":"11","author":"Arimitsu","year":"2003","journal-title":"Clin Diag Lab Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T03:35:47Z","timestamp":1736912147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07002435"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}